中华神经外科杂志
中華神經外科雜誌
중화신경외과잡지
Chinese Journal of Neurosurgery
2009年
6期
508-512
,共5页
姜政%周伟%李新钢%于金明%江玉泉
薑政%週偉%李新鋼%于金明%江玉泉
강정%주위%리신강%우금명%강옥천
神经胶质瘤%DNA甲基化%基因调节
神經膠質瘤%DNA甲基化%基因調節
신경효질류%DNA갑기화%기인조절
Glioma%DNA methylation%Gene regulation
目的 检测胶质瘤CXCL12基因启动子区的甲基化状态及其mRNA表达水平,以及受体CXCR4、DNA甲基转移酶等基因的mRNA表达情况,分析甲基化在CXCL12/CXCR4生物轴参与胶质瘤恶性进展中的调控机制.方法 半定量RT-PCR和实时定量PCR检测CXCL12、CXCR4、DNMT1、DNMT3A和DNMT3B基闪在76例胶质瘤及10例正常脑组织中的表达情况;甲基化PCR检测CXCL12基因启动子区的甲基化状态.结果 (1)CXCR4 mRNA随胶质瘤恶性程度的增高而表达增加;(2)CXCL12基因在胶质瘤中的甲基化率为34.2%,甲基化率随胶质瘤恶性程度的增高而降低;(3)CXCL12基因的甲基化主要发生在低度恶性胶质瘤中,其甲基化状态与mRNA表达密切相关;(4)DNMT1、DNMT3A和DNMT3B在CXCL12基因甲基化胶质瘤中的表达明显高于未发生甲基化的胶质瘤.结论 CXCR4基因有望成为胶质瘤恶性程度的生物学标志;CXCL12基因启动子区的甲基化主要发生在低度恶性胶质瘤中,其CXCL12基因甲基化下调mRNA的表达;DNMT1、DNMT3A和DNMT3B的过表达可能参与CXCL12基因甲基化的调控.
目的 檢測膠質瘤CXCL12基因啟動子區的甲基化狀態及其mRNA錶達水平,以及受體CXCR4、DNA甲基轉移酶等基因的mRNA錶達情況,分析甲基化在CXCL12/CXCR4生物軸參與膠質瘤噁性進展中的調控機製.方法 半定量RT-PCR和實時定量PCR檢測CXCL12、CXCR4、DNMT1、DNMT3A和DNMT3B基閃在76例膠質瘤及10例正常腦組織中的錶達情況;甲基化PCR檢測CXCL12基因啟動子區的甲基化狀態.結果 (1)CXCR4 mRNA隨膠質瘤噁性程度的增高而錶達增加;(2)CXCL12基因在膠質瘤中的甲基化率為34.2%,甲基化率隨膠質瘤噁性程度的增高而降低;(3)CXCL12基因的甲基化主要髮生在低度噁性膠質瘤中,其甲基化狀態與mRNA錶達密切相關;(4)DNMT1、DNMT3A和DNMT3B在CXCL12基因甲基化膠質瘤中的錶達明顯高于未髮生甲基化的膠質瘤.結論 CXCR4基因有望成為膠質瘤噁性程度的生物學標誌;CXCL12基因啟動子區的甲基化主要髮生在低度噁性膠質瘤中,其CXCL12基因甲基化下調mRNA的錶達;DNMT1、DNMT3A和DNMT3B的過錶達可能參與CXCL12基因甲基化的調控.
목적 검측효질류CXCL12기인계동자구적갑기화상태급기mRNA표체수평,이급수체CXCR4、DNA갑기전이매등기인적mRNA표체정황,분석갑기화재CXCL12/CXCR4생물축삼여효질류악성진전중적조공궤제.방법 반정량RT-PCR화실시정량PCR검측CXCL12、CXCR4、DNMT1、DNMT3A화DNMT3B기섬재76례효질류급10례정상뇌조직중적표체정황;갑기화PCR검측CXCL12기인계동자구적갑기화상태.결과 (1)CXCR4 mRNA수효질류악성정도적증고이표체증가;(2)CXCL12기인재효질류중적갑기화솔위34.2%,갑기화솔수효질류악성정도적증고이강저;(3)CXCL12기인적갑기화주요발생재저도악성효질류중,기갑기화상태여mRNA표체밀절상관;(4)DNMT1、DNMT3A화DNMT3B재CXCL12기인갑기화효질류중적표체명현고우미발생갑기화적효질류.결론 CXCR4기인유망성위효질류악성정도적생물학표지;CXCL12기인계동자구적갑기화주요발생재저도악성효질류중,기CXCL12기인갑기화하조mRNA적표체;DNMT1、DNMT3A화DNMT3B적과표체가능삼여CXCL12기인갑기화적조공.
Objective To detect the methylation status of CXCL12 gene and the mRNA expression of CXCL12, CXCR4 and DNA methyhransferases (DNMTs) in glioma, and to analyze the methylation regulation and mechanism of CXCL12/CXCR4 signaling axis in the malignant progress of glioma. Methods The mRNA expression of CXCL12, CXCR4, DNMT1, DNMT3A and DNMT3B was detected by the semi - quantitative RT - PCR and real - time PCR in 76 gliomas and 10 normal brain tissues. The methylation status of CXCL12 in glioma was also studied by the methylation specific PCR. Results ( 1 ) The mRNA expression of CXCR4 in glioma increased with WHO grades. (2) Methylation of CXCL12 was detected in 34. 2% ( 26/76 ) of gliomas, but the methylation rate decreased with WHO grades. ( 3 ) Epigenetic inactivation of CXCL12 mainly happened in low- grade gliomas, and the CXCL12 mRNA levels were closely related to its methylation status. (4) The expression levels of these three DNMT genes were significantly higher in the CXCL12 - methylated gliomas than in the CXCL12 - unmethylated ones. Conclusion The CXCR4 gene may be a marker of aggressive biological behavior of glioma. The CXCL12 promoter hypermethylation is detected mainly in low - grade gliomas. And the methylaiton of CXCL12 gene cause the down - regulation of its mRNA levels in low - grade gliomas. The high expressions of DNMT1、DNMT3A and DNMT3B may be the potential mechanism of CXCL12 methylation.